✦ LIBER ✦

Results of a Phase II Open-Label Study of Capecitabine in Combination with Irinotecan as First-Line Treatment for Metastatic Colorectal Cancer

✍ Scribed by Thomas Cartwright; Timothy Lopez; Svetislava J. Vukelja; Carlos Encarnacion; Kristi A. Boehm; Lina Asmar

Book ID: 119934981
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 485 KB
Volume: 5
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2005.n.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in combination with biweekly

Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer

✍ García-Alfonso, P; Muñoz-Martin, A J; Alvarez-Suarez, S; Jerez-Gilarranz, Y; Rie 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 243 KB

707 PUBLICATION Capecitabine, oxaliplati

707 PUBLICATION Capecitabine, oxaliplatin and irinotecan combination: a first line treatment for metastasic colorectal cancer, preliminary results of a phase II study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 269 KB

277 Combination of irinotecan and capeci

277 Combination of irinotecan and capecitabine as first line treatment in advanced colorectal cancer (ACC): results of a phase II multicenter trial

✍ C.J.A. Punt; J.W.R. Nortier; W.W. ten Bokkel Huinink; S. Falk; D.J. Richel; T. M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

3068 POSTER Capecitabine + irinotecan +

3068 POSTER Capecitabine + irinotecan + bevacizumab as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC): preliminary phase II study results

✍ S. Beslija; M. Banjin; S. Jungic; N. Obralic; G. Kecman-Malcic; I. Rakita; B. Sa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

CPT-11 in combination with capecitabine

CPT-11 in combination with capecitabine as first line chemotherapy for metastatic colorectal cancer (MCRC): preliminary results of a phase I/II study

✍ Kerr, D.J.; Ten Bokkel Huinink, W.W.; Bakker, J.; Boussard, B.; Frings, S.; Nort 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Randomized multicenter Phase II trial of

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

✍ Emilio Bajetta; Maria Di Bartolomeo; Luigi Mariani; Antonio Cassata; Salvatore A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as first‐line treatment in metastatic colorectal carcinoma (CRC). ## METHODS A total of 140 patients received capecitabine at a dose of 1